Credit: UK Photo | Mark Cornelison
Dr. Linda Van Eldik, Director of the UK Sanders-Brown Center on Aging, in her lab. A $2.8 million NIH grant will underwrite preclinical studies of a novel drug with potential to treat multiple forms of dementia simultaneously.